Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility.

Annals of internal medicine - 18 Jul 2017

Wynn Julia, Chung Wendy K

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genetic Testing
Share to Genotype
Share to United States

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to United States Food and Drug Administration

Source

Identifiers

PMID: 28554190
DOI: 10.7326/M17-1045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility.PMID 28554190Read ↗

23andMe resumes giving consumers genetic health information: Company's tests for rare and common diseases aren't diagnostic.Semantic proximity Read ↗

23andMe, the Food and Drug Administration, and the future of genetic testing.Semantic proximity Read ↗

Statement of the ESHG on direct-to-consumer genetic testing for health-related purposesSemantic proximity Read ↗

Risks of presymptomatic direct-to-consumer genetic testing.Semantic proximity Read ↗

Genetic tests for common diseases: new insights, old concerns.Semantic proximity Read ↗

The Need to Improve the Clinical Utility of Direct-to-Consumer Genetic Tests: Either Too Narrow or Too Broad.Semantic proximity Read ↗

The future of direct-to-consumer clinical genetic testsSemantic proximity Read ↗

[The genome and the consumer].Semantic proximity Read ↗

Direct‐to‐consumer genetic testing: Perspectives on its value in healthcareSemantic proximity Read ↗

Are we ready for direct-to-consumer genetic testing?Semantic proximity Read ↗

Promises and perils of using genetic tests to predict risk of disease.Semantic proximity Read ↗

Global burden of genetic disease and the role of genetic screeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.